OAPL Ethics Committee

From time to time, ethically difficult decisions arise when further external advice is required to assure not only editorial independence but also due process. The OAPL Ethics Committee is an independent subcommittee to which difficult editorial issues are referred by a senior editor after the in-house process has been exhausted or and the issue has not been resolved. A senior editor will be either the OAPL journal Editor-in-Chief or an In-House Editor. The committee will give specific guidance when consulted to the senior editor. The committee will be made up of independent clinicians and scientists. A range of issues may be confronted which may include but are not limited to instances of conflicts of interest, research ethics, publication ethics and author or reviewer conduct and probity. This committee will not replace research or governmental institutional ethics committee roles but are advisory for publication matters arising in OAPL. Confidentiality will be expected of all members.


The current OAPL Ethics Committee Members are:


Benedict C. Albensi, University of Manitoba, Canada


Heike Allgayer, University of Heidelberg, Germany


Srikumar P. Chellappan, Moffitt Cancer Center, United States


Kris Dierickx, Katholieke Universiteit Leuven, Belgium


Thomas Efferth, Johannes Gutenberg University of Mainz, Germany


Michael Van Dyke, Western Carolina University, United States


John H. Halpern, Harvard Medical School, United States